Go to SC301 Plastic Surgery AI Consultation Request
Sera AI Consultation
Sera AI Consultation
Go to SC301 Plastic Surgery AI Consultation Request
Skip to main content
301 blog

Stem cell breast augmentation is gaining popularity among postpartum women as well.

By 2021-01-05No Comments

Addressing the shortcomings of fat grafting… Raising the engraftment rate to 75%

Ms. Lee Mi-young (pseudonym, 35), who married in her early 30s and gave birth to a daughter, is worried about the changes in her body shape after breastfeeding. She tried to get back in shape and exercise to resume her work as a Pilates instructor, but her sagging breasts and abdomen were difficult to recover even with exercise. Ms. Lee was planning body contouring surgery, including breast augmentation, to return her figure to what it was before marriage, when she came across a medical paper on stem cell breast augmentation on the recommendation of her husband, who is a doctor. As she makes plans for the body contouring surgery, she is excited at the thought of regaining her former figure.

As the age of childbirth is delayed, significant changes are occurring in women's body shapes after delivery. Generally, the changes women experience after childbirth include stretch marks on the abdomen and sagging breasts. In the case of breasts, for example, they enlarge for breastfeeding but deflate and lose volume once nursing ends, causing them to sag downwards. Consequently, many women wish to return to their pre-pregnancy bodies through dieting or exercise, but realistically, it is difficult to achieve the same results as before childbirth. This is the background behind the growing interest in breast surgery. Recently, coupled with controversies regarding the safety of breast implants, interest in breast fat grafting (transplanting one's own fat) and stem cell breast augmentation has increased.

Breast fat grafting, which is evaluated as having relatively fewer side effects than breast implant surgery, has not been well-received due to its low engraftment rate. However, recently, as the engraftment rate of stem cell breast surgery has been proven in international papers, it is establishing itself as a new form of breast augmentation. Dr. Shin Dong-jin, director of SC301 Clinic, who specializes in stem cell breast augmentation, has researched breast fat grafting exclusively for the past 15 years to prove the efficacy of stem cells. He published clinical results in the SCIE-level Oxford Journal of Aesthetics, demonstrating an average engraftment rate (75%) of breast fat grafting using stem cells.

Dr. Shin, who was the first in Korea to clinically introduce stem cell breast augmentation, performed breast surgery using stem cells while researching improvements to address the shortcomings of conventional breast fat grafting. After more than 10 years of medical research, he developed a stem cell breast surgery method that enhances safety and effectiveness. In particular, as word spread that Dr. Shin's stem cell breast augmentation is effective and has few side effects for women after childbirth, it is becoming increasingly popular among women who have finished breastfeeding.

Stem cell breast surgery involves harvesting fat from areas such as the thighs and abdomen. This offers the advantage of providing cosmetic effects not only on the breasts but also on the overall body shape. Director Shin stated, "We verified the engraftment rate obtained after stem cell breast augmentation by datafying and analyzing thousands of surgical cases," adding, "Caution is required as there has recently been an increase in similar surgeries that lure patients with low prices."